220
Participants
Start Date
March 30, 2009
Primary Completion Date
May 18, 2011
Study Completion Date
March 14, 2016
Prochymal®
Intravenous infusion of ex vivo cultured adult human mesenchymal stem cells
Placebo
Intravenous infusion of excipients of Prochymal®
Stony Brook University Medical Center, Stony Brook
University at Buffalo - Buffalo General Hospital, Buffalo
Allegheny General Hospital, Pittsburgh
Penn State University - Milton S. Hershey Medical Center, Hershey
Drexel University College of Medicine, Philadelphia
University of Maryland Hospital, Baltimore
Wake Forest University School of Medicine, Winston-Salem
University of Miami, Miami
Mount Sinai Medical Center, Miami Beach
The Stern Cardiovascular Center, Germantown
The Ohio State University Medical Center, Columbus
The Lindner Research Center, Cincinnati
The Care Group, Indianapolis
William Beaumont Hospital, Royal Oak
Michigan Cardiovascular Institute, Saginaw
University of Iowa Hospitals and Clinics, Iowa City
University of Wisconsin School of Medicine, Madison
Minneapolis Heart Institute, Minneapolis
Rush University Medical Center, Chicago
Cotton-O'Neil Clinical Research Center, Topeka
University of Texas Health Science Center, Houston
Austin Heart P.A., Austin
Mercy Gilbert Medical Center / Catholic Health Care West, Gilbert
University of Arizona, Tucson
University of California - San Diego (UCSD), San Diego
UC Davis Medical Center, Sacramento
Oregon Health & Science University, Portland
Tufts Medical Center, Boston
Baystate Medical Center, Springfield
UMass Memorial Medical Center, Worcester
UMDNJ - Robert Wood Johnson Medical School, New Brunswick
Fletcher Allen Health Care, Burlington
McGill University Health Centre, Montreal
Lead Sponsor
Mesoblast, Inc.
INDUSTRY